Labcorp Holdings Inc. (NYSE:LH) Q2 2025 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q2 2025 Labcorp Holdings Earnings Conference Call.
Labcorp Holdings Inc. (LH)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Te Ahumairangi Investment Management Nicholas Bagnall | 0 | $0 | 0% | |
| 2. | Gotham Asset Management Joel Greenblatt | 0 | $0 | 0% | |
| 3. | Hourglass Capital Kenneth A. Moffet | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $231.20 | 44 | $10,250.96 | 14,282 | 2022-09-07 | Filing | |
| $242.19 | 42 | $10,173.56 | 14,172 | 2022-06-07 | Filing | |
| $264.57 | 600 | $158,742.00 | 10,254 | 2022-02-16 | Filing | |
| $263.98 | 1,600 | $422,368.00 | 9,654 | 2022-02-16 | Filing | |
| $262.85 | 1,300 | $341,705.00 | 8,054 | 2022-02-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $264.95 | 2,000 | $529,900.00 | 6,656 | 2025-07-30 | Filing | |
| $261.04 | 100 | $26,103.50 | 1,852 | 2025-07-29 | Filing | |
| $261.01 | 102 | $26,623.04 | 1,952 | 2025-07-29 | Filing | |
| $280.00 | 3,500 | $980,000.00 | 8,666 | 2025-07-24 | Filing | |
| $280.00 | 3,500 | $980,000.00 | 8,666 | 2025-07-24 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 22,889 | $6,008,652 | 0.93% | |
| 2. | 8,780 | $2,304,838 | 1.38% | |
| 3. | 2,500 | $656,275 | 0.19% | |
| 4. | 776 | $203,708 | 0.07% | |
| 5. | 128 | $33,601 | 0.01% |
News See All
Morgan Stanley Hikes Labcorp (LH) Holdings Price Target to $283 Affirms ‘Overweight’ Rating
Laboratory Corporation of America Holdings (NYSE:LH) is one of the best healthcare stocks to buy now.
12 Best Healthcare Stocks to Buy Now
Healthcare companies in the US are facing policy headwinds under President Donald Trump's Administration.
Laboratory Corporation of America Holdings (NYSE:LH) Q1 2025 Earnings Call Transcript
Laboratory Corporation of America Holdings (NYSE:LH) Q1 2025 Earnings Call Transcript April 29, 2025Laboratory Corporation of America Holdings beats earnings expectations.
Laboratory Corporation of America Holdings (NYSE:LH) Q4 2024 Earnings Call Transcript
Laboratory Corporation of America Holdings (NYSE:LH) Q4 2024 Earnings Call Transcript February 6, 2025Laboratory Corporation of America Holdings beats earnings expectations.
7 Stocks on Jim Cramer's Radar
Jim Cramer, host of Mad Money, shared his thoughts on factors that could lead to market growth in 2025, pointing out some key changes that could benefit investors.
Laboratory Corporation of America Holdings (NYSE:LH) Q3 2024 Earnings Call Transcript
Laboratory Corporation of America Holdings (NYSE:LH) Q3 2024 Earnings Call Transcript October 24, 2024Laboratory Corporation of America Holdings beats earnings expectations.
Should You Invest in Labcorp Holdings (LH)?
Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Laboratory Corporation of America Holdings (NYSE:LH) Q2 2024 Earnings Call Transcript
Laboratory Corporation of America Holdings (NYSE:LH) Q2 2024 Earnings Call Transcript August 1, 2024Laboratory Corporation of America Holdings beats earnings expectations.
Labcorp Holdings (LH) is Trading at an Attractive Valuation
Diamond Hill Capital, an investment management company, released its “Large Cap Strategy” first-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Billionaire Hedge Funds
